DEBRA Research is a non-profit organisation dedicated to advancing treatments and cures for Epidermolysis Bullosa (EB), a group of rare and painful genetic skin conditions. As the research arm of DEBRA Austria – a patient organization supporting individuals living with EB since 1995 – we collaborate globally with academia, biotech, pharma, patient organizations, and regulatory bodies to drive innovation.
Our focus is on accelerating translational research and supporting clinical development to address the unmet needs of people living with EB. We aim to improve quality of life while striving for a future where EB is curable – a world without EB.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Goethestrasse 52, München,80336,germany
- Industry
- Non-Profit Organizations
- Website
- https://www.debra-research.org/
- Keywords
- LEO Pharma España.
- HQ
- München
Debra Research Questions
Debra Research's website is https://www.debra-research.org/
Debra Research's LinkedIn profile is https://de.linkedin.com/company/debra-research
Debra Research has
7 employees.
View email and phone details for 7
employees at Debra Research.
Debra Research's industry is
Non-profit Organizations
Debra Research's top competitors are
Boehringer Ingelheim,
Leo Pharma,
Redbow Consulting Group,
Tempnest - Furnished Rentals,
Leo Pharma España,
Laboratorios Gebro Pharma,
Dermaliq Therapeutics, Inc.,
Debra Uk,
Bio Medical Engineering,
Clinica Dr Morales Raya.
Debra Research's categories are Non-profit Organizations
Debra Research's founding year is 2023
